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SUMMARY
Histaminergic neurons in the tuberomammilary nu-
cleus (TMN) of the hypothalamus form a widely pro-
jecting, wake-active network that sustains arousal.
Yet most histaminergic neurons contain GABA. Se-
lective siRNA knockdown of the vesicular GABA
transporter (vgat,SLC32A1) in histaminergic neurons
produced hyperactive mice with an exceptional
amount of sustained wakefulness. Ablation of the
vgat gene throughout the TMN further sharpened
this phenotype. Optogenetic stimulation in the
caudate-putamen and neocortex of ‘‘histaminergic’’
axonal projections from the TMNevoked tonic (extra-
synaptic) GABAA receptor Cl
 currents onto medium
spiny neurons and pyramidal neurons. These cur-
rents were abolished following vgat gene removal
from the TMN area. Thus wake-active histaminergic
neurons generate a paracrine GABAergic signal
that serves to provide a brake on overactivation
from histamine, but could also increase the precision
of neocortical processing. The long range of hista-
mine-GABA axonal projections suggests that extra-
synaptic inhibition will be coordinated over large
neocortical and striatal areas.
INTRODUCTION
Histaminergic neurons in the tuberomammilary nucleus (TMN), a
region of the posterior hypothalamus, help sustain wakefulness
(Anaclet et al., 2009; Haas et al., 2008; Lin et al., 1988, 1989;
Monnier et al., 1967; Nicholson et al., 1991; Parmentier et al.,
2002, 2009; Saper et al., 2010; Wada et al., 1991; Yu et al.,
2014). They are the sole source of neuronal histamine and
send axons throughout the brain (Bayliss et al., 1990; Panula
et al., 1984; Watanabe et al., 1983). TMN neurons become active
just after waking and fire at an average rate of about 5 Hz, and
their activity is suppressed during sleep (Sakai et al., 2010; Saper
et al., 2010; Takahashi et al., 2006). Histaminemodulates diverse
circuitries (Ellender et al., 2011; Haas et al., 2008; Wada et al.,
1991). Histamine can suppress, for example, glutamate or
GABA inputs to local circuits by activating hetero-H3 metabo-
tropic receptors on terminals; it can also depolarize cells via
H1 and H2 metabotropic receptors or cause phosphorylation
of ion channels that influence firing rate (Atzori et al., 2000;
Ellender et al., 2011). These effects can occur in the same local
circuitry. At the behavioral level, the net effects of histamine’s
actions on circuits are enhanced aspects of wakefulness such
as cognition, locomotion, feeding, and motivation (Torrealba
et al., 2012).
Physiological investigations have focused on the histaminer-
gic aspect of TMN neurons. But these neurons also contain glu-
tamic acid decarboxylase (GAD) enzymes and GABA itself
(Airaksinen et al., 1992; Senba et al., 1985; Takeda et al., 1984;
Trottier et al., 2002; Vincent et al., 1983). GABA’s presence in his-
taminergic neurons is conserved, from fish through to humans,
suggesting a core function (Sundvik and Panula, 2012; Trottier
et al., 2002). It is not known what this function is, and there has
been no demonstration that these cells actually release GABA.
Optogenetic stimulation of histaminergic fibers in the ventral
lateral preoptic (VLPO) area of the hypothalamus found that his-
tamine release stimulated local GABAergic interneurons (Wil-
liams et al., 2014), but provided no evidence of GABA release
from the histamine fibers.
Varicosities on TMN axons broadcast histamine by volume
transmission—histaminergic neurons rarely use synapses (Ta-
kagi et al., 1986). So it is likely that if these same TMN axons
do release GABA, then this particular source of GABA would
also function, similar to histamine, in a paracrine manner that
would principally affect extrasynaptic receptors. Because
GABA is an electroneutral zwitterion at physiological pH, it
has diminished interactions with the extracellular matrix.
Thus GABA is well suited for diffusion over long distances (Rob-
erts and Sherman, 1993). Ambient (nonsynaptic) GABA pro-
duces sustained inhibitory currents by activating high-affinity
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extrasynaptic ionotropic GABAA receptors (Brickley et al., 1996;
Brickley and Mody, 2012; Lee and Maguire, 2014); this is termed
the tonic inhibitory conductance (Gtonic).
In this paper we start by showing that selective pharmacoge-
netic stimulation of histamine neurons enhances behavioral
arousal. We then demonstrate that knocking down or removing
vgat gene expression from histaminergic neurons increases
locomotion, and causes a substantial increase in wakefulness
during the night. Optogenetically stimulating histaminergic fibers
in the neocortex and caudate-putamen increasesGtonic onto py-
ramidal neurons and medium spiny cells, respectively. Elimi-
nating vgat from histaminergic neurons selectively abolishes
these evoked tonic inhibitory currents. Thus, during wakeful-
ness, GABA can be deposited widely in neocortical and striatal
circuitry by volume transmission. The GABA and histamine
TMN components work together to regulate the amount of
wakefulness.
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Figure 1. Pharmacogenetic Activation of
Histaminergic Neurons Increased Motor
Activity of HDC-hM3Dq Mice
(A) AAV-flex-hM3Dq-mCherry was bilaterally in-
jected into the TMN region of HDC-Cre mice
to give hM3Dq-mCherry expression selectively
within histaminergic neurons (see inset image).
(B) Activity of HDC-hM3Dq mice in an open field
arena 30min after saline (black trace, n = 4mice) or
CNO (red trace, n = 4 mice) injection. The distance
moved was calculated every 5 min and average
values (mean ± SEM) plotted over 60 min (*p <
0.05; **p < 0.01).
(C) Double-label immunocytochemisty of HDC-
and hM3Dq-mCherry-positive neurons with HDC
antisera and mCherry antibody; arrowheads indi-
cate examples of double-labeled neurons. DAPI
labeling was included to locate all cells.
(D) Two examples of voltage traces recorded from
HDC-hM3Dq mice during the application of CNO.
The top trace shows an example of a silent neuron
that was sufficiently depolarized to fire APs. The
bottom trace shows a spontaneously active
neuron with increased AP firing in the presence of
CNO. On average there was a significant (paired
t test, p < 0.05) 5 mV depolarization of TMN
neurons (n = 11 cells, control, 46 ± 3 mV;
CNO, 41 ± 2 mV). The results from each cell are
shown on the scatterplot on the right.
RESULTS
Histaminergic Neurons Stimulate
Arousal but Are Also GABAergic
We first tested the excitatory nature
of histaminergic neurons on behavior
by selectively stimulating them pharma-
cogenetically in vivo with DREADD
hM3Dq-mCherry receptors and cloza-
pine-N-oxide (CNO) (Alexander et al.,
2009; Krashes et al., 2011). The hM3Dq
receptor is an excitatory metabotropic re-
ceptor. Histaminergic neurons can be
genetically targeted because of their unique expression of the
histidine decarboxylase (hdc) gene, allowing the generation of
HDC-Cre mice (Yu et al., 2014; Zecharia et al., 2012). The TMN
area of HDC-Cre mice was bilaterally transduced with AAV-
flex-hM3Dq-mCherry (Figure 1A) to produce HDC-hM3Dq
mice. Intraperitoneal administration of CNO, but not saline, to
these HDC-hM3Dq mice significantly increased their motor ac-
tivity in an open area (Figure 1B) (saline, n = 4; CNO, n = 4,
two-way ANOVA and post hoc Bonferroni, *p < 0.05; **p <
0.01; measurements taken 30 min post CNO or saline injection).
In these mice, the hM3Dq-mCherry receptor was selectively ex-
pressed in most histaminergic neurons (348 mCherry-positive
cells out of 405 HDC-positive cells were counted across three
animals; 85% ± 3.5% of the HDC-neurons were mCherry posi-
tive) (Figure 1C). Using whole-cell recording in acute slices
from the TMN area ofHDC-hM3Dqmice (n = 4mice), we demon-
strated that CNO significantly (paired t test, p < 0.05) depolarized
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TMN neurons by 5 mV (n = 11 cells, control, 46 ± 3 mV;
CNO, 41 ± 2 mV). This was sufficient to elicit action potential
(AP) firing in silent cells (5 out of 11) or increase AP firing rate in
spontaneously active cells (Figure 1D). Thus, selectively acti-
vating histaminergic neurons generated hyperlocomotion and
behavioral arousal.
In spite of this excitatory effect on behavior, histaminergic
TMN cells contain GABA and its synthetic enzyme GAD67
(gad1) (Airaksinen et al., 1992; Takeda et al., 1984; Vincent
et al., 1983). By immunocytochemistry, we found that a majority
of HDC-positive neurons costained strongly with GAD67 anti-
sera (1,399 GAD67-positive cells out of 1,720 HDC-positive cells
were counted across three animals; 81%± 10%of the HDC neu-
rons were GAD67 positive; Figure 2A). We corroborated this
result genetically by crossing HDC-Cre mice with conditional
rosa-lox-stop-lox-YFP mice (Srinivas et al., 2001). In these
crosses, 85% ± 5% (n = 3 mice) of YFP-positive neurons in the
TMN also expressed GAD67 (Figure 2B). Conventionally, if hista-
minergic neurons were to release GABA, they should also ex-
press the vesicular GABA transporter (vgat, Slc32a1) gene.
With the exception of midbrain dopamine neurons (Tritsch
et al., 2012, 2014), vGAT has so far proved essential for all neu-
rons that release GABA (Tong et al., 2008; Wojcik et al., 2006);
vgat expression, however, has not been demonstrated for HDC
cells. Crossing vGAT-Cre mice (Vong et al., 2011) with those
containing a rosa-lox-stop-lox-tdTomato allele (Madisen et al.,
2010) gave extensive tdTomato/HDC soma costaining in the
TMN (Figure 2C). Thus histaminergic neurons express the vgat
gene and have the potential to package GABA into vesicles.
Genetic Disruption of GABA Function in Histaminergic
Neurons
To remove the putative GABAergic function from histaminergic
neurons, we considered crossing either vgatlox/loxmice or double
gad1lox/lox/gad2lox/loxmice with theHDC-Cremice. However, the
hdc-cre, vgat, gad1, and gad2 genes are all in the same region of
mouse chromosome 2, which precluded easy generation of ho-
mozygousHDC-Cre/vgatlox/lox orHDC-Cre/gad1lox/lox/gad2lox/lox
A B
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Figure 2. The Majority of Histaminergic Neurons Express GABAergic Markers
(A) Coronal section of the mouse posterior hypothalamus stained with HDC (green) and GAD67 (red) antisera. The diagram summarizes the staining from the
whole TMN region: HDC-positive cells (green) and double-positive cells (orange). 3V, third ventricle; VTM, ventral tuberomammillary; DTM, diffuse
tuberomammillary.
(B) HDC-Cre mice were crossed with Rosa26-loxP-stop-loxP-YFP mice to generate HDC-YFP mice. TMN sections from HDC-YFP mice were costained with
EYFP and GAD67 antisera. Most YFP-positive (HDC neurons) in the TMN were also GAD67-positive.
(C) vGAT-Cre mice were crossed with Rosa26-loxP-stop-loxP-tdTomato mice to generate vGAT-tdTomato mice. Sections from vGAT-tdTomato mice were
stained with HDC antisera. Most HDC neurons were tdTomato positive.
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Figure 3. Knocking Down and Knocking Out vgat Expression from Histaminergic Neurons in the TMN
(A) Three hairpin (sh) oligonucleotides (sholigo), targeting the vgat transcript, were designed. Each sholigowas separately cloned into the pPRIME-dsRed vector;
a scramble shRNA was also cloned into pPRIME-dsRed.
(B) To test the knockdown efficiency of the three shvgat oligonucleotides in vitro,CMV-dsRed-scramble orCMV-dsRed-shvgat (1, 2, or 3) were cotransfectedwith
pCMV-vGAT-30UTR (a cDNA containing the vgat open reading frame and 30 untranslated region) into HEK293 cells. Thirty-six hours later, cells were fixed and
stained with vGAT antisera. vGAT expression was best reduced with sholigo1 and sholigo3.
(C) Three independent transfections were performed, and relative vGAT immunofluorescence in HEK cells was quantified.
(legend continued on next page)
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animals. We therefore developed vgat-selective shRNA con-
structs to knock down vgat expression (Figure 3 and see Fig-
ure S1 available online). For this we placed putative vgat shRNA
sequences into a microRNA gene, mir30, in the 30 untranslated
region of a transcript that also encodes dsRed (Stegmeier
et al., 2005). These constructs were termed dsRed-shvgat
(oligo1, oligo2, or oligo3) (Figure 3A). We tested how well these
constructs could reduce vgat reporter gene expression in trans-
fected HEK293 cells by cotransfecting dsRed-shvgat (oligo1,
oligo2, or oligo3) with CMV-vGAT, respectively. Two shRNAs
strongly knocked down vgat reporter gene expression in HEK
cells (Figures 3B and 3C, p < 0.05, t test). Before moving to the
more challenging area of the TMN, we used a striatum-based
motor assay to demonstrate that the constructs, delivered in
AAVs, worked effectively in vivo (Figure S1). To compare the
behavior produced by knockdown and knockout of vGAT in
the caudate-putamen (CPu), we unilaterally injected AAV-
dsRed-shvgat and AAV-Cre-2A-Venus into wild-type and
vgatlox/lox mice, respectively, to generate CPu-vgat KD and
CPu-Dvgat mice (Figures S1A and S1D). Both CPu-vgat KD
and CPu-Dvgat groups had significantly decreased vgat tran-
script levels (Figures S1B and S1E) and increased ipsilateral
turning compared with controls (Figures S1C and S1F).
To knock down vgat expression selectively in histaminergic
neurons, we placed the dsRed-shvgat and dsRed-scramble
cassettes in reverse orientation between heterologous lox sites
(a FLEX switch) (Figure 3D), so that expression could only be
induced by CRE recombinase (Atasoy et al., 2008). The AAV-
flex-dsRed-shvgat or AAV-flex-dsRed-scramble viruses were
bilaterally injected into the TMN area of HDC-Cre mice (Fig-
ure 3D). The groups of mice are referred to as HDC-vgat KD
and HDC-scramble, respectively. We also injected AAV-Cre-
2A-Venus and AAV-GFP into the TMN area of vgatlox/lox mice
to produce TMN-Dvgat and TMN-GFP mice, respectively (Fig-
ure 3F). In TMN-Dvgat mice, the injections covered the TMN
area; 77% ± 2% of HDC-positive neurons expressed Cre-2A-
Venus (Figure S2). In the TMN, all of the GAD67-positive neurons
also contained HDC (Figure 2A). These TMN-Dvgatmice formed
an approximate comparison for the HDC-vgat KDmice, with the
caveat that some GABAergic cells in the TMN area in addition to
the histaminergic cells could be affected. We tested the vgat
gene expression levels in the TMN area of HDC-vgat KD and
TMN-Dvgatmice by both qPCR on tissue punches and also sin-
gle-cell qPCR from identified neurons in acute brain slices pre-
pared from the TMN area (Figure S3). The tissue-punch analysis
showed that in both TMN-Dvgat and HDC-vgat KD mice, vgat
mRNA levels in the TMNwere significantly decreased compared
with those in TMN-GFP or HDC-scramble mice (TMN-GFP,
1 ± 0.06 versus TMN-Dvgat, 0.5 ± 0.06, t test, **p < 0.01; HDC-
scramble, 1 ± 0.04 versus HDC-vgat KD, 0.76 ± 0.05, t test,
*p < 0.05) (Figures S3A–S3C). The single-cell qPCR showed
that in both TMN-Dvgat and HDC-vgat KD mice, the vgat
mRNA levels from identified single neurons were also signifi-
cantly decreased compared with those in TMN-GFP or HDC-
scramble mice (TMN-GFP, 1 ± 0.46 versus TMN-Dvgat, 0.06 ±
0.02, t test, *p < 0.05; HDC-scramble, 1 ± 0.24 versus HDC-
vgat KD, 0.35 ± 0.17, t test, *p < 0.05) (Figures S3D–S3G). The
content of histamine in the neocortex and caudate-putamen of
HDC-vgat KD and TMN-Dvgat mice was unchanged (see
Figure S4).
HDC-vgat KD and TMN-Dvgat Mice Are Hyperactive
We first quantified the general activity of the mice. In an open
field assay, HDC-vgat KD mice ran significantly further and had
higher instantaneous speeds than the HDC-scramble controls,
maintaining a stable and high activity for the 30 min duration of
the test (Figure 3E; HDC-scramble, n = 7; HDC-vgat KD, n = 8,
two-way ANOVA and post hoc Bonferroni, *p < 0.05; **p <
0.01). Similarly, the TMN-Dvgat mice were continuously more
active compared with TMN-GFP control mice (Figure 3G;
TMN-GFP, n = 10; TMN-Dvgat, n = 6, two-way ANOVA and
post hoc Bonferroni, **p < 0.01; ***p < 0.001). In fact, the activity
of the TMN-Dvgat mice, as measured by instantaneous speed
and distance covered, tended to increase toward the end of
the experiment (Figure 3G).
HDC-vgat KD and TMN-Dvgat Mice Have Increased and
Sustained Wakefulness during the Night
We used EEG/EMG analysis to assess the sleep-wake cycle
(Figures 4 and S5A). The HDC-vgat KD and TMN-Dvgatmice ex-
hibited similar changes in their sleep-wake behavior, largely
confined to the night. First we describe the HDC-vgat KD
(n = 6) and HDC-scramble (n = 6) groups (Figures 4A–4C and
S5B). For the first half of the night,HDC-vgat KDmice had signif-
icantly more wake than the HDC-scramble controls (Figures 4A,
4B, and S5B) (wake, HDC-scramble, 400 ± 13 min versus HDC-
vgat KD, 511 ± 15 min, t test, ***p < 0.001). The example in Fig-
ure 4A shows the EEG from an HDC-vgat KD mouse that was
awake continuously for 6 hr during the first half of the night. In
fact, during the night, HDC-vgat KD mice had only about 65%
of normal NREM sleep compared with HDC-scramble mice
(NREM, HDC-scramble, 293 ± 12 min versus HDC-vgat KD,
190 ± 14 min, t test, ***p < 0.001). Their REM sleep was also
slightly decreased (HDC-scramble, 22 ± 2 min versus HDC-
vgat KD, 17 ± 2 min, t test, *p < 0.05). The EEG q power of
HDC-vgat KDmice was significantly increased selectively during
the night (Figure 4C) (two-way ANOVA and post hoc Bonferroni,
***p < 0.001), consistent with the heightened wakefulness of
(D)AAV-flex-dsRed-shvgat (oligo3)was bilaterally injected into the TMN region ofHDC-Cremice. Cre recombination produced dsRed-shvgat expression in HDC-
positive neurons, and the resulting mice were termed HDC-vgat KD mice. Arrowheads indicate examples of colabeled cells.
(E) HDC-vgat KD mice were more active than HDC-scramble (AAV-flex-dsRed-scramble-injected HDC-Cre) mice in an open field assay (*p < 0.05; **p < 0.01).
(F) AAV-Cre-2A-Venus was bilaterally injected into the TMN region of vgatlox/lox mice to generate TMN-Dvgat mice. Sections from virus-injected (TMN-Dvgat)
mice were costained with HDC and GFP (Venus) antisera. In the TMN region, GFP expression was in 77% ± 2% of HDC neurons. Arrowheads indicate examples
of colabeled cells.
(G) TMN-Dvgatmice ran further than TMN-GFP (AAV-GFP-injected vgatlox/lox) mice in an open field assay (**p < 0.01; ***p < 0.001). During each running episode
TMN-Dvgat mice also ran faster, as evidenced by instantaneous speed measurements (**p < 0.01; ***p < 0.001).
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Figure 4. GABA Release from Histaminergic Neurons Governs the Amount of Sleep
(A) Continuous EMG, EEG, delta power, wake, NREM sleep, and REM sleep scoring data recorded for an HDC-scramble and an HDC-vgat KDmouse for 24 hr.
(B) The graphs illustrate the average 24 hr sleep scoring (percentage of wake, NREM, or REM sleep) forHDC-scramble (black trace) and HDC-vgat KD (red trace)
mice; bars, SEM.
(legend continued on next page)
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HDC-vgat KDmice (Figure 4B). In the day, both theHDC-vgat KD
andHDC-scramblemice showed a similar sleep-wake pattern—
with the same amount of NREM sleep and wake (Figures 4A, 4B,
and S5B; wake, HDC-scramble (n = 6), 243 ± 10 min versus
HDC-vgat KD (n = 6), 252 ± 18 min, t test, p > 0.05; NREM,
HDC-scramble (n = 6), 425 ± 10 min versus HDC-vgat KD
(n = 6), 409 ± 12 min, t test, p > 0.05).
Similar to HDC-vgat KD mice, TMN-Dvgat mice had a strong
‘‘sustained wakefulness’’ phenotype confined to the night (Fig-
ures 4D, 4E, and S5C). Compared with the TMN-GFP controls
(n = 5), TMN-Dvgat (n = 7) animals were awake nearly the whole
night (TMN-GFP, 411 ± 9 min versus TMN-Dvgat, 586 ± 27 min,
t test, ***p < 0.001). Conversely, these TMN-Dvgat mice ex-
hibited little NREM sleep during the dark period (Figures 4E
and S5C; TMN-GFP, 258 ± 12 min versus TMN-Dvgat, 118 ±
25 min, t test, **p < 0.01). Their amount of REM sleep was also
decreased (TMN-GFP, 48 ± 9 min versus TMN-Dvgat, 13 ±
3 min, t test, **p < 0.01). Similar to the HDC-vgat KDmice, selec-
tively during the night, TMN-Dvgatmice had a strong increase of
their maximum q power frequency (Figure 4F). Thus both the
HDC-vgat KD and TMN-Dvgatmice slept less. Their loss of sleep
during the dark phase was not balanced by a corresponding in-
crease in sleep duration during the day (two-way ANOVA and
post hoc Bonferroni, ***p < 0.001).
After Sleep Deprivation, HDC-vgat KD and TMN-Dvgat
Mice Still Sleep Less Than Control Mice, Maintaining
Their Hyperactive State
Given the lack of sleep displayed by the HDC-vgat KD and TMN-
Dvgatmice during a typical 24 hr cycle, we investigated how they
behaved after sleep deprivation. Compared with control mice,
would they demonstrate more recovery sleep to compensate
for general lack of sleep during the normal sleep-wake cycle?
Mice were sleep deprived for 5 hr during the beginning of the
day by presenting them with novel objects. After sleep depriva-
tion, mice were allowed recovery sleep in their home cages (Fig-
ure S6). Comparedwith the control mice,HDC-vgat KDmice had
less NREM recovery sleep (Figures S6A and S6B), but the rate at
which they reaccumulated their lost NREM sleep (12.5 extra
minutes NREM sleep recovered/hour) was similar to controls
(Figure S6C). TMN-Dvgatmice behavedmore extremely (Figures
S6D and S6E). After sleep deprivation they were awake longer
than control sleep-deprived mice and some 16 hr after sleep
deprivation were spendingmost of their time awake (Figure S6E).
However, as for the TMN-Dvgat mice, the rate at which they re-
accumulated their lost NREM sleep (12 extra minutes NREM
sleep recovered/hour) was similar to controls (Figure S6F).
Thus HDC-vgat KD and TMN-Dvgatmice sleep less than control
mice, maintaining their hyperactive state even after sleep
deprivation.
Histaminergic Axons in Neocortex and Striatum Release
Paracrine GABA
Histamine neurons can globally coordinate behavioral states
because their axons spread and diverge throughout the brain
(Panula et al., 1989; Takagi et al., 1986; Wada et al., 1991).
Can the axonal projections of histaminergic neurons release
GABA, and does this release require vGAT? The behavioral re-
sults with HDC-vgat KD and TMN-Dvgat mice imply that this is
the case. We addressed this directly using optogenetic stimula-
tion in two types of mice: HDC-Channel-Rhodopsin(ChR) mice
and TMN-Dvgat/HDC-ChR mice. To make HDC-ChR mice, the
TMN area of HDC-Cre mice was bilaterally injected with AAV-
flex-ChR2H134R-EYFP (Figures 5A and 5B). A TMN acute slice
from HDC-ChR mice with ChR-EYFP primary fluorescence is
shown in Figure 5B. The ChR-EYFP fusion protein was enriched
in the membrane of HDC-neurons, including their axons (Figures
5B and 5C). Brief 1 ms stimuli were delivered to the LED every
200 ms, resulting in a 460 nm 0.1 mW/mm2 peak light pulse
that decayed with a time course of 10 msec. A continuous
5 Hz protocol was delivered for 3 min to HDC-ChR-EYFP-posi-
tive neurons in acute TMN slices (Figure 5D). This ChR stimula-
tion protocol was capable of entraining action potential firing
at 5 Hz (Figure 5E), corresponding to wake-active firing rates of
TMN neurons (Takahashi et al., 2006). The ChR-EYFP fusion
protein is an excellent substrate for anterograde axonal transport
(Petreanu et al., 2007; Tye and Deisseroth, 2012). EYFP-positive
fibers, marking the presence of ChR, were present in both
the caudate-putamen (Figures 5F and 5G) and all neocortical
areas examined e.g., sensory, motor, and visual neocortex (Fig-
ures 5H and 5I). The TMN-Dvgat/HDC-ChRmice have light-sen-
sitive HDC neurons with deleted vgat gene expression. To make
these, we coinjected AAV-Cre-2A-Venus and AAV-flex-ChR2-
EYFP bilaterally into the TMN area of vgatlox/lox mice (Figures
6A and 6B).
We carried out functional circuit mapping by light-stimulating
the ChR-EYFP labeled fibers in the neocortex (Figure 6C) and
caudate-putamen (Figure 6J) prepared from TMN-Dvgat/HDC-
ChR and HDC-ChR mice. Stimulation of HDC-ChR neocortical
slices with brief light pulses delivered at 5 Hz generated slow
and sustained increases in the holding current recorded, in
whole-cell mode, from pyramidal cells (Figure 6D). This current
resembled the Gtonic produced by activation of extrasynaptic
GABAA receptors (Brickley et al., 1996; Brickley and Mody,
2012; Bright et al., 2007; Wisden et al., 2002). On average, Gtonic
significantly increased by 1.1 ± 0.3 nS (paired t test, p < 0.01;
n = 8) in the HDC-ChR slices (Figure 6E). In the example shown
(Figure 6D), the enhancement of Gtonic was apparent after a few
minutes of 5 Hz continuous optical stimulation, consistent with
GABA diffusing to its target receptors from distant release sites
(i.e., a paracrine action). To determine whether the GABA was
(C) Comparison of the power spectra of wake obtained from EEG data recorded during the day and night for the HDC-scramble (black trace) and HDC-vgat KD
(red trace) mice.
(D) Continuous EMG, EEG, delta power, wake, NREM sleep, and REM sleep scoring data recorded from TMN-GFP and TMN-Dvgat mice.
(E) The graphs illustrate the average 24 hr sleep scoring (percentage of wake, NREM, or REM sleep) for TMN-GFP (black trace) and TMN-Dvgat (red trace) mice;
bars, SEM.
(F) Comparison of the power spectra of wake obtained from EEG data recorded during the day and night for the TMN-GFP (black trace) and TMN-Dvgat (red
trace) mice.
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being released directly from HDC terminals or if this required an
interneuron intermediate, we repeated these experiments in the
presence of TTX (1 mM) and 4-AP (100 mM) (Root et al., 2014).
A robust increase in Gtonic was observed, and on average it
significantly increased by 0.5 ± 0.1 nS (paired t test, p < 0.01;
n = 9) in the HDC-ChR slices (Figure 6F). In contrast, there was
no increase in Gtonic in TMN-Dvgat/HDC-ChR slices following
5 Hz light stimulation (Figure 6G). On average Gtonic was slightly
reduced by 0.2 ± 0.1 nS (n = 9) in the TMN-Dvgat/HDC-ChR
mice (paired t test, p = 0.225, n = 9; Figure 6H). This suggests
that vesicular GABA was being directly released from the hista-
minergic fibers using GABAergic (vGAT-dependent) vesicles to
cause the increase in Gtonic. The results also imply that the Gtonic
is not caused by activating any putative histamine-gated chlo-
ride channels (Fleck et al., 2012).
We next confirmed, independently of the HDC-specific vgat
knockouts, that histamine release was not responsible for stim-
ulating GABAergic interneurons to release GABA. We repeated
the 5 Hz light stimulation of HDC-ChR fibers in the presence of
the H1 receptor antagonist pyrilamine (20 mM) and the H2 recep-
tor antagonist ranitidine (5 mM). A significant increase in Gtonic
(0.6 ± 0.2 nS, n = 11; paired t test, p < 0.05) still occurred (Fig-
ure 6I), and as before, the increase was delayed after the onset
of light stimulation. Applying H1/H2 receptor antagonists further
suggested that there was no intermediary GABAergic inter-
neuron involved that first required excitation by histamine, and
which then released GABA to increase Gtonic. Instead, GABA
release in the neocortex from TMN axons was vGAT dependent.
ChR-EYFP-positive fibers were also present in the caudate
putamen of HDC-ChR mice (Figure 6J). During 5 Hz light stimu-
lation, there was a gradual increase in Gtonic (1.9 ± 0.6 nS, n = 7;
paired t test, p < 0.05) onto medium spiny neurons (Figure 6K).
When the GABAA receptor antagonist gabazine (100 mM) was
present during the stimulation, there was no increase in Gtonic;
in fact, on average it decreased by 0.8 ± 0.5 nS (n = 6)
(Figure 6L).
GABA Released from Histaminergic Axons Does Not
Increase Phasic Inhibition, but Histamine Increases
Synaptic Drive
We examined if GABA release from ‘‘GABA-histaminergic’’
axons in neocortex of HDC-ChR mice increased phasic (synap-
tic) GABAA receptor activation, in addition to its ability to raise
Gtonic. The timing of sPSCs was analyzed relative to the LED
trigger (Figure 7A). By cross-correlation analysis, sPSCs were
not phase locked with ChR stimulation (Figure 7B) (n = 9 record-
ings from four HDC-ChR mice). However, the sPSC frequency
significantly increased in these neocortical slices from 6.4 ±
1.7 Hz (n = 9) to 9.5 ± 2.2 Hz (paired t test, p < 0.05). This increase
in asynchronous sPSC frequency was not observed when these
experiments were repeated in the presence of TTX/4-AP (Fig-
ure 7C), although Gtonic did significantly increase (see Figure 6F).
A similar increase in sPSC frequency was observed in the TMN-
Dvgat/HDC-ChR mice, where the sPSC frequency increased
from 8.7 ± 2.8 Hz (n = 9) to 15.6 ± 3.3 Hz (paired t test, p <
0.05). However, in these mice there was no increase in Gtonic
(see Figure 6H). Does this light-evoked increase in sPSC rate
depend on histamine release? In the presence of the H1 receptor
antagonist pyrilamine (20 mM) and the H2 receptor antagonist
ranitidine (5 mM), the ChR-stimulated increase in the rate of
asynchronous sPSCs was blocked at the start and at the end
of stimulation (Figure 7D; 23.9 ± 6.0 Hz [start] to 21.9 ± 5.4 Hz
[end]; n = 11, paired t test, p = 0.3). For neocortical layer neurons,
these data highlight the independent nature of the two signals
from histaminergic-GABA axons originating from the TMN: an
increased synaptic drive generated by histamine release and
an increased Gtonic generated by GABA release.
DISCUSSION
Histamine neurons form a globally projecting hub that integrates
brain functions associated with wakefulness (Wada et al., 1991).
Starting in the TMN, histaminergic axons course large distances
throughout the brain, generating extrasynaptic pools of trans-
mitter. We showed that selective pharmacogenetic stimulation
of these histamine neurons in vivo behaviorally excites the ani-
mals, as would be expected (Haas et al., 2008; Lin et al., 1988;
Monnier et al., 1967; Nicholson et al., 1991). But we also estab-
lished that histaminergic neurons use vGAT to release GABA.
Similar to histamine, the GABA released from histaminergic neu-
rons functions in a paracrine manner, which would make these
neurons an unexpected source of GABAergic volume transmis-
sion in the neocortex and striatum. As part of their integrative
role in specifying behavioral state, we expect that these hypotha-
lamic TMN ‘‘GABA-histamine’’ neuronswill contribute to tonic in-
hibition of many neural circuits simultaneously. Mice whose
GABA-histamine neurons cannot release GABA are hyperactive,
and they sleep less and do not catch up on this lost sleep. The
Figure 5. Selective ChR2-EYFP Expression in Histaminergic Neurons and Tracing Their Axons to Neocortex and Striatum
(A) AAV-flex-ChR2-EYFPwas bilaterally injected into the TMN region ofHDC-Cremice. The blue circle indicates the area of the slice that was optically stimulated.
(B) Cre recombination produced ChR2-EYFP expression within HDC-expressing neurons. Shown is a combined bright-field and primary fluorescence photo-
graph, taken at low magnification, of a freshly cut coronal brain slice used for electrophysiological recording from TMN neurons.
(C) ChR-EYFP expression in the TMN imaged with antisera to GFP (green) and HDC (red), with arrowheads indicating ChR2 expression in processes.
(D) The duration of the LED power output (blue trace) measured from the objective lens, and the membrane voltage recorded (black trace) from the soma of a
HDC-ChR2-EYFP neuron. Increasing the LED power depolarized the membrane to generate action potentials. Inset image: four neurons recorded from this slice
with cofluorescence for ChR-EYFP (green) and postrecording neurobiotin fill (red).
(E) The same cell as (D) firing action potentials with 5 Hz light stimulation.
(F) Schematic of the fibers (axons) which, following AAV-flex-ChR2-EYFP injection into the TMN of HDC-Cremice, transported ChR-EYFP from the HDC-ChR2-
EYFP soma into the neocortex and caudate-putamen.
(G and H) Low-power photographs of theChR2-EYFP-positive fibers in the caudate-putamen (CPu) (G) and sensory and visual cortex (H). Blue, DAPI; I, layer I; II,
layer II; III, layer III; IV, layer IV; V, layer V; VI, layer VI; WM, white matter.
(I) Schematic of the ChR2-EYFP fiber distribution in the caudate-putamen (CPu) and neocortex.
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Figure 6. Histaminergic Axons Produce Slow GABAergic Responses in Visual Cortex Pyramidal and Striatal Neurons
(A) Double injection of AAV-Cre-Venus and AAV-flex-ChR2-EYFP into the TMN of vgatlox/lox mice to make light-sensitive histaminergic neurons that lack vGAT
(HDC-ChR TMN-Dvgat mouse).
(B) The top photomicrograph shows combined expression of the two AAV transgenes in the bilateral TMN area (coronal section). The lower picture shows double
staining in the TMN with HDC and EGFP antisera.
(C) Two layer IV pyramidal neurons filled with neurobiotin/Alexa 555 (red) postrecording.
(D) Electrophysiological data from a HDC-ChR mouse. The gray symbols superimposed upon the current trace (black line) show the average holding current
calculated for every 1 s epoch during the entire recording. An increase in the holding current begins during the 5 Hz optogenetic stimulation but takes minutes to
reach its peak response following termination of the stimuli.
(E) Scatterplot for all recordings made from the HDC-ChRmice. The lines indicate paired recordings made before and after the 5 Hz optogenetic stimulation. On
average, Gtonic significantly increased by 1.1 ± 0.3 nS (paired t test, p < 0.01; n = 8) in the HDC-ChR slices.
(legend continued on next page)
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‘‘sleepless phenotype’’ manifests during the night. Their
behavior might be described as a form of mania (Kirshenbaum
et al., 2011), which in humans would be considered as part of
a bipolar disorder.
Neurons often corelease small molecules and peptides (Ada-
mantidis, 2015; Klausberger and Somogyi, 2008; Scho¨ne and
Burdakov, 2012; Tong et al., 2008; van den Pol, 2012). ‘‘Orexi-
nergic’’ neurons, for example, in the lateral hypothalamus core-
lease glutamate and orexin onto histaminergic neurons in the
TMN (Scho¨ne et al., 2014). The different time course of the excit-
atory actions of the two transmitters (glutamate, fast synaptic
excitation; orexin, slow and sustained excitation) allows them
to signal different aspects of ‘‘metabolic integration’’ (Scho¨ne
et al., 2014). In addition to peptides, some neurons release
several small molecule transmitters simultaneously, sometimes
of the same functional type, e.g., GABA-glycine (Jonas et al.,
1998), but often of functionally antagonist pairings, for example,
GABA-glutamate, or GABA-acetylcholine or GABA-dopamine
(Hnasko and Edwards, 2012; Vaaga et al., 2014). In contrast to
our findings on GABA-histamine neurons, other investigations
into GABA cotransmission or corelease, including cotransmis-
sion with peptides, found only fast monosynaptic responses
generated by the GABA component (Jego et al., 2013; Root
et al., 2014; Shabel et al., 2014; Tong et al., 2008; Tritsch et al.,
2012). It might be expected that midbrain dopamine and hista-
mine networks function similarly with respect to GABA release,
but they do not. GABA is not synthesized in the dopamine neu-
rons themselves—unlike the histamine neurons, they do not ex-
press the gad1 or gad2 genes—but GABA is instead scavenged
into dopaminergic terminals by the transporters mGAT1 and
mGAT4; it is hypothesized that GABA is then transported into
dopamine vesicles by the monoamine transporter VMAT2
(Tritsch et al., 2012, 2014). For histamine neurons, vgat knockout
removes GABA release; the VMAT2 in histamine neurons does
not substitute for vGAT. In cultured TMN neurons from embryos,
GABA is in putative vesicles distinct from histaminergic ones,
suggesting cotransmission rather than corelease (Kukko-Lukja-
nov and Panula, 2003).
There is an intriguing potential for synergy directly at the re-
ceptor level between histamine and GABA. At (high) concentra-
tions of around 1 mM, histamine is an effective positive allosteric
modulator of a4 subunit-containing GABAA receptors (Bianchi
et al., 2011), which are the type of GABAA receptors often asso-
ciated with extrasynaptic activation (Brickley and Mody, 2012).
However, when we removed vgat from histamine (HDC-ChR)
axons, this abolished the light-evoked increase in tonic inhibition
on layer IV pyramidal neurons, suggesting that the histamine
released was not sufficient to activate any a4 subunit-containing
GABAA receptors that might have been present. Similarly, the
vgat deletion experiment also ruled out that the increase inGtonic
was due to activating (speculative) histamine-gated chloride
channels (Fleck et al., 2012). In the absence of vGAT, light trig-
gered a general increase in synaptic drive onto pyramidal neu-
rons, which was blocked by H1 and H2 receptor antagonists.
This effect of histamine is likely to reflect the engagement of mul-
tiple changes in the inputs impinging onto pyramidal neurons, as
described for striatal neurons (Ellender et al., 2011). As the hista-
mine system innervates most of the brain, further studies will be
required to see if GABA is coreleased in other areas. In the
ventral lateral preoptic hypothalamus, histamine axons do not
release GABA when stimulated optogentically, but instead acti-
vate GABA interneurons by histamine release (Williams et al.,
2014). By contrast, our experiments using TTX in the neocortex
suggest that in this brain region no intermediary interneurons
convey TMN axon-evoked GABA release. About 20% of hista-
mine neurons in the TMN only contain histamine (Figure 2A),
and these could be the ones that innervate VLPO.
The ‘‘GABA-histamine’’ TMN neurons only fire during wake-
fulness, so GABA will be released from their axons into the
neocortex and striatum during the wake state. The paracrine
nature of the GABA signal explains the lack of any phasic
synaptic inhibition associated with GABA release from the hista-
mine axons. Why would GABA-histamine neurons use contra-
dictory ‘‘stop-go’’ signals? One reason could be to stop
networks getting too excited by histamine: the HDC-vgat KD
and TMN-Dvgat mice are more active and sleep less because
the histaminergic system is overactive. The function of sleep
is unknown, but an overactive histamine system, resulting in
less sleep, may damage health and cause mania. GABA release
from histamine neurons could keep the animal in the ‘‘optimal
arousal zone.’’
A second reason could be related to the fact that in the
awake neocortex, inhibition enhances processing (Haider
et al., 2013). Indeed, the wake-active GABAergic volume
transmission generated by TMN neurons may sharpen cogni-
tive responses, and so GABA could work together with
histamine to enhance wakefulness. Increased ambient GABA
levels will generate greater Gtonic, which by speeding up the
(F) Scatterplot for all recordings made from the HDC-ChRmice in the presence of TTX and 4-AP. On average, Gtonic significantly increased by 0.5 ± 0.1 nS (paired
t test, p < 0.005; n = 9) in the HDC-ChR slices.
(G) Electrophysiological data from aHDC-ChR TMN-Dvgatmouse. The gray symbols superimposed upon the current trace (black line) show the average holding
current calculated every 1 s epoch for the entire recording. No change in the holding current occurred in response to the 5 Hz optogenetic stimulation, but there
was an increase in the frequency of spontaneous synaptic activity (transient downward deflections).
(H) Scatterplots for recordings made from the HDC-ChR TMN-Dvgatmice. The lines indicate the paired recordings made before and after the 5 Hz optogenetic
stimulation. Gtonic was reduced by 0.2 ± 0.1 nS in the TMN-Dvgat/HDC-ChR mice (paired t test, p = 0.225, n = 9).
(I) Scatterplots for recordings made from the HDC-ChR mice in the presence of H1 (pyrilamine) and H2 (ranitidine) blockers. Gtonic increased by 0.6 ± 0.2 nS
(paired t test, p < 0.05; n = 11).
(J) Medium spiny neuron (red, neurobiotin fill postrecording) from the caudate-putamen of a HDC-ChR mouse; several ChR-EYFP-positive axons (green) are in
the vicinity of the cell.
(K and L) Scatterplots for all recordings made from medium spiny neurons in the HDC-ChR mice in control conditions and with the GABAA receptor antagonist
gabazine (10 mM). Gtonic increased by 1.9 ± 0.6 nS (paired t test, p < 0.05; n = 7) in control conditions and decreased by0.8 ± 0.5 nS in the presence of gabazine
(paired t test, p = 0.3; n = 6).
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membrane time constant will increase the requirement for
EPSP-spike precision, and constrain coincidence detection
so that only closely timed inputs trigger action potentials (Brick-
ley and Mody, 2012; Bright et al., 2007; Duguid et al., 2012;
Hamann et al., 2002; Wlodarczyk et al., 2013). The long dis-
tances traversed by the GABA-histamine axons mean that
extrasynaptic inhibition could be coordinated by the TMN
over large cortical areas.
In conclusion, we think it is no longer correct to refer to TMN
neurons as ‘‘histaminergic’’: the GABA arm of their activity is
so striking that they might be referred to as ‘‘GABA-histamine’’
neurons. We have demonstrated that the wide-ranging GABA-
histamine axons of the hypothalamic TMN broadcast dual inhib-
A
B
C
D
Figure 7. Activated Neocortical ‘‘GABA-His-
tamine’’ Axons Increase Synaptic Drive and
Gtonic by Independent Mechanisms
(A) Whole-cell voltage-clamp recording from a
pyramidal cell in layer IV of visual cortex during
5 Hz LED stimulation of axon fibers from an
HDC-ChR mouse. The left-hand trace is from the
start, and the right-hand trace is at the end of,
the 5 Hz LED stimuli. The increased holding cur-
rent between the first and last trace was used
to calculate the increase in tonic conductance
(DGtonic).
(B) Cross-correlation analyses between the LED
trigger and the occurrence of sPSCs. There was
no peak in the histogram, consistent with a lack of
LED-triggered PSCs.
(C) Whole-cell voltage-clamp recording in a layer
IV pyramidal cell in the presence of TTX and 4-AP
during 5-Hz LED stimulation of axon fibers in the
visual neocortex from an HDC-ChR mouse. There
was an increase in Gtonic but in this experiment
little change in sPSC rate.
(D) Scatterplot of the change in synaptic drive (Hz)
onto layer IV visual cortex pyramidal cells for the
four main experiments: stimulation of HDC-ChR
axons, stimulation of HDC-ChR axons in the
presence of TTX/4-AP, stimulation of HDC-ChR
axons in the presence of H1 and H2 receptor
antagonists, and stimulation of TMN-Dvgat/HDC-
ChR axons. In HDC-ChR mice the sPSC fre-
quency significantly increased from 6.4 ± 1.7 Hz
(n = 9) to 9.5 ± 2.2 Hz (paired t test, p < 0.05). In
TMN-Dvgat/HDC mice, a similar increase in sPSC
frequency was observed from 8.7 ± 2.8 Hz (n = 9)
to 15.6 ± 3.3 Hz (paired t test, p < 0.05). With the
H1 receptor antagonist pyrilamine (20 mM) and the
H2 receptor antagonist ranitidine (5 mM), the ChR-
stimulated increase in the rate of asynchronous
sPSCs was 23.9 ± 6.0 Hz at the start and 21.9 ±
5.4 Hz at the end of stimulation (n = 11, paired
t test, p = 0.3).
itory-excitatory signals in the neocortex:
an increased Gtonic generated by GABA
release, and an increased synaptic
drive generated by histamine. The two
components may work together to regu-
late the amount of wakefulness. If this
balance of GABA-histamine cotransmission changes unfavor-
ably, mania-like behaviors could emerge.
EXPERIMENTAL PROCEDURES
Animals
All experiments were performed in accordance with the UK Home Office
Animal Procedures Act (1986); all procedures were approved by the
Imperial College Ethical Review Committee. The following strains of mice
were used: HDC-Cre (129SVJ and C57BL/6J) (Zecharia et al., 2012) (JAX
stock number 021198); Rosa26-loxP-Stop-loxP-YFP (C57BL/6J), kindly
provided by F. Costantini (Srinivas et al., 2001); vgatlox/lox (C57BL/6J and
129S4), kindly provided by B.B. Lowell (Tong et al., 2008) (Jax stock number
012897); vGAT-Cre, kindly provided by B.B. Lowell (Vong et al., 2011); and
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Rosa26-loxP-Stop-loxP-tdTomato, kindly provided by H. Zeng (Madisen
et al., 2010). See Supplemental Information for genotyping.
AAV Transgene Plasmids
Plasmid pAAV-iCre-2A-Venus was provided by Thomas Kuner (Abraham
et al., 2010). Plasmid pAAV-GFP was a gift from John T. Gray (Addgene
plasmid 32396). Plasmid pAAV-EF1a-flex-ChR2H134R-EYFP was a gift from
Karl Deisseroth (Addgene plasmid 20298). The H134R mutation enhances
light-evoked ChR currents and reduces spike-frequency adaptation (Nagel
et al., 2005; Pulver et al., 2009). Plasmid pAAV-hSyn-flex-hM3Dq-mCherry
was a gift from Bryan L. Roth (Addgene plasmid 44361) (Krashes et al.,
2011). The pPRIME system, cloned into AAV transgenes, was used to generate
shRNAs in vivo (Stegmeier et al., 2005). See Supplemental Information for
shRNA sequences.
Adeno-Associated Virus Preparation and Stereotaxic Injections
To produce adeno-associated virus (AAV), the adenovirus helper plasmid
pFD6, the AAV helper plasmids pH21 (AAV1) and pRVI (AAV2), and the
pAAV transgene plasmids were cotransfected into HEK293 cells and the
subsequent AAV particles harvested on heparin columns, as described previ-
ously (Klugmann et al., 2005). To deliver the AAV into the brain, stereotaxic
injections were performed using an Angle Two apparatus (Leica) linked to a
digital brain atlas (Leica Biosystems Richmond, Inc.). Before injection, 1 ml
AAV virus was mixed with 1 ml 20% mannitol (MERCK K93152782 111). The
virus and mannitol mixture were injected into a pulled-glass pipette (Warner
Instruments; OD = 1.00mm, ID = 0.78mm, length = 7.5 cm). Virus was injected
at a speed of 25 nl/min. Virus (1 ml) was bilaterally injected into the brain,
0.5 ml for each side. For TMN, the injection coordinates were as follows:
ML (0.92 mm), AP (2.70 mm), DV (5.34 mm); ML (0.92 mm), AP
(2.70 mm), and DV (5.34 mm). For unilateral injections, the injection coordi-
nates were as follows: CPu, ML (2.10 mm), AP (0.50 mm), and DV
(3.66 mm).
Histamine Measurements
Neocortex or striatum was collected and homogenized with 10 ml of 0.2 M
perchloric acid per mg tissue and centrifuged at 10,000 rpm for 5 min at
4C. The supernatants were collected and neutralized with an equal volume
of 1 M potassium borate buffer. Brain histamine levels were determined with
an ELISA kit (Beckman Coulter Co. number IM2562).
qPCR on Tissue Punches and Single-Cell qPCR
Total RNA from tissue punches was extracted using Trizol (Invitrogen).
Reverse transcription and PCR were performed using a TaqMan RNA-to-Ct
1-Step Kit (Life Technologies, 4392653) and an Applied Biosystems machine
(Foster City, USA). Acute slices of the TMN area weremade (see ‘‘Electrophys-
iology’’). AAV-transduced neurons were identified by fluorescence. After
patching and recording (see ‘‘Electrophysiology’’), we used the Single-Cell-
to-CT Kit (Ambion). The content of the neuron was aspirated into the recording
pipette and expelled into cell lysis/DNase I solution. Reverse transcription
and cDNA preamplification were performed according to the kit protocol.
qPCR was performed using the TaqMan Gene Expression Assay system.
The TaqMan assay probes were designed and purchased from Invitrogen
(UK): mvgat, Mm00494138_m1; m18srRNA, Mm03928990_g1; and mhdc,
Mm00456104_m1.
EEG Analysis and Sleep-Wake Behavior
EEG and EMG signals were recorded using Neurologger 2A devices (Anisimov
et al., 2014; Yu et al., 2014). The sleep state (wake, W; non-rapid eye move-
ment, NREM; rapid eye movement, REM; doubt, D) was scored manually.
See Supplemental Information for details. The sleep deprivation procedure,
with presentation of novel objects, was performed as described (Yu et al.,
2014).
General Behavioral Activity: Open Field Assay
All experiments were performed during ‘‘lights off’’ (active phase). The
locomotion activity was detected in an activity test chamber with infrared
sensors (Med Associates, Inc). The ‘‘instantaneous speed’’ was calculated
as the distance traveled divided by the time spent moving (but not including
the time the mice spent in the stationary state). For the DREADD experiments,
clozapine-N-oxide (C0832, Sigma-Aldrich, dissolved in saline, 5 mg/kg) or
saline was administered i.p. 30 min before the start of the behavioral
observations.
Electrophysiology
Acute brain slices were prepared as described in Supplemental Information.
For optogenetic experiments, a 470 nm collimated LED (M470L3-C1, Thor-
labs) was used to illuminate the slice through the objective lens, and current-
clamp recordings were first made from histaminergic neurons to confirm
ChR2 expression. Subsequent voltage-clamp experiments in neocortex and
stratum were used for cross-correlation analysis of synaptic events using a
100 ms sliding window before and after each LED pulse. Changes in the tonic
GABAA receptor-meditated conductance (Gtonic) were calculated from the
average holding current.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article at http://dx.doi.org/10.1016/j.
neuron.2015.06.003.
ACKNOWLEDGMENTS
This work was supported by the Medical Research Council, UK (G0901892,
S.G.B., N.P.F., and W.W.; G0800399, W.W.), the BBSRC (G021691 and BB/
K018159/1, S.G.B., N.P.F., and W.W.), the Wellcome Trust (WT094211MA,
S.G.B., N.P.F., and W.W.), and a UK-China Scholarships for Excellence/China
Scholarship scheme (X.Y. and Z.Y.).
Received: January 9, 2015
Revised: April 29, 2015
Accepted: May 27, 2015
Published: June 18, 2015
REFERENCES
Abraham, N.M., Egger, V., Shimshek, D.R., Renden, R., Fukunaga, I.,
Sprengel, R., Seeburg, P.H., Klugmann, M., Margrie, T.W., Schaefer, A.T.,
and Kuner, T. (2010). Synaptic inhibition in the olfactory bulb accelerates
odor discrimination in mice. Neuron 65, 399–411.
Adamantidis, A.R. (2015). Sleep: the sound of a local alarm clock. Curr. Biol.
25, 49–50.
Airaksinen, M.S., Alanen, S., Szabat, E., Visser, T.J., and Panula, P. (1992).
Multiple neurotransmitters in the tuberomammillary nucleus: comparison of
rat, mouse, and guinea pig. J. Comp. Neurol. 323, 103–116.
Alexander, G.M., Rogan, S.C., Abbas, A.I., Armbruster, B.N., Pei, Y., Allen,
J.A., Nonneman, R.J., Hartmann, J., Moy, S.S., Nicolelis, M.A., et al. (2009).
Remote control of neuronal activity in transgenic mice expressing evolved G
protein-coupled receptors. Neuron 63, 27–39.
Anaclet, C., Parmentier, R., Ouk, K., Guidon, G., Buda, C., Sastre, J.P.,
Akaoka, H., Sergeeva, O.A., Yanagisawa, M., Ohtsu, H., et al. (2009).
Orexin/hypocretin and histamine: distinct roles in the control of wakefulness
demonstrated using knock-out mouse models. J. Neurosci. 29, 14423–14438.
Anisimov, V.N., Herbst, J.A., Abramchuk, A.N., Latanov, A.V., Hahnloser, R.H.,
and Vyssotski, A.L. (2014). Reconstruction of vocal interactions in a group of
small songbirds. Nat. Methods 11, 1135–1137.
Atasoy, D., Aponte, Y., Su, H.H., and Sternson, S.M. (2008). A FLEX switch tar-
gets Channelrhodopsin-2 to multiple cell types for imaging and long-range cir-
cuit mapping. J. Neurosci. 28, 7025–7030.
Atzori, M., Lau, D., Tansey, E.P., Chow, A., Ozaita, A., Rudy, B., and McBain,
C.J. (2000). H2 histamine receptor-phosphorylation of Kv3.2 modulates inter-
neuron fast spiking. Nat. Neurosci. 3, 791–798.
176 Neuron 87, 164–178, July 1, 2015 ª2015 The Authors
Bayliss, D.A., Wang, Y.M., Zahnow, C.A., Joseph, D.R., and Millhorn, D.E.
(1990). Localization of histidine decarboxylase mRNA in rat brain. Mol. Cell.
Neurosci. 1, 3–9.
Bianchi, M.T., Clark, A.G., and Fisher, J.L. (2011). The wake-promoting trans-
mitter histamine preferentially enhances a-4 subunit-containing GABAA re-
ceptors. Neuropharmacology 61, 747–752.
Brickley, S.G., and Mody, I. (2012). Extrasynaptic GABA(A) receptors: their
function in the CNS and implications for disease. Neuron 73, 23–34.
Brickley, S.G., Cull-Candy, S.G., and Farrant, M. (1996). Development of a
tonic form of synaptic inhibition in rat cerebellar granule cells resulting from
persistent activation of GABAA receptors. J. Physiol. 497, 753–759.
Bright, D.P., Aller, M.I., and Brickley, S.G. (2007). Synaptic release generates a
tonic GABA(A) receptor-mediated conductance that modulates burst preci-
sion in thalamic relay neurons. J. Neurosci. 27, 2560–2569.
Duguid, I., Branco, T., London, M., Chadderton, P., and Ha¨usser, M. (2012).
Tonic inhibition enhances fidelity of sensory information transmission in the
cerebellar cortex. J. Neurosci. 32, 11132–11143.
Ellender, T.J., Huerta-Ocampo, I., Deisseroth, K., Capogna, M., and Bolam,
J.P. (2011). Differential modulation of excitatory and inhibitory striatal synaptic
transmission by histamine. J. Neurosci. 31, 15340–15351.
Fleck, M.W., Thomson, J.L., and Hough, L.B. (2012). Histamine-gated ion
channels in mammals? Biochem. Pharmacol. 83, 1127–1135.
Haas, H.L., Sergeeva, O.A., and Selbach, O. (2008). Histamine in the nervous
system. Physiol. Rev. 88, 1183–1241.
Haider, B., Ha¨usser, M., and Carandini, M. (2013). Inhibition dominates sen-
sory responses in the awake cortex. Nature 493, 97–100.
Hamann,M., Rossi, D.J., and Attwell, D. (2002). Tonic and spillover inhibition of
granule cells control information flow through cerebellar cortex. Neuron 33,
625–633.
Hnasko, T.S., and Edwards, R.H. (2012). Neurotransmitter corelease: mecha-
nism and physiological role. Annu. Rev. Physiol. 74, 225–243.
Jego, S., Glasgow, S.D., Herrera, C.G., Ekstrand, M., Reed, S.J., Boyce, R.,
Friedman, J., Burdakov, D., and Adamantidis, A.R. (2013). Optogenetic iden-
tification of a rapid eye movement sleep modulatory circuit in the hypothala-
mus. Nat. Neurosci. 16, 1637–1643.
Jonas, P., Bischofberger, J., and Sandku¨hler, J. (1998). Corelease of two fast
neurotransmitters at a central synapse. Science 281, 419–424.
Kirshenbaum, G.S., Clapcote, S.J., Duffy, S., Burgess, C.R., Petersen, J.,
Jarowek, K.J., Yu¨cel, Y.H., Cortez, M.A., Snead, O.C., 3rd, Vilsen, B., et al.
(2011). Mania-like behavior induced by genetic dysfunction of the neuron-spe-
cific Na+,K+-ATPase a3 sodium pump. Proc. Natl. Acad. Sci. USA 108,
18144–18149.
Klausberger, T., and Somogyi, P. (2008). Neuronal diversity and temporal dy-
namics: the unity of hippocampal circuit operations. Science 321, 53–57.
Klugmann, M., Symes, C.W., Leichtlein, C.B., Klaussner, B.K., Dunning, J.,
Fong, D., Young, D., and During, M.J. (2005). AAV-mediated hippocampal
expression of short and long Homer 1 proteins differentially affect cognition
and seizure activity in adult rats. Mol. Cell. Neurosci. 28, 347–360.
Krashes, M.J., Koda, S., Ye, C., Rogan, S.C., Adams, A.C., Cusher, D.S.,
Maratos-Flier, E., Roth, B.L., and Lowell, B.B. (2011). Rapid, reversible activa-
tion of AgRP neurons drives feeding behavior in mice. J. Clin. Invest. 121,
1424–1428.
Kukko-Lukjanov, T.K., and Panula, P. (2003). Subcellular distribution of hista-
mine, GABA and galanin in tuberomamillary neurons in vitro. J. Chem.
Neuroanat. 25, 279–292.
Lee, V., andMaguire, J. (2014). The impact of tonic GABAA receptor-mediated
inhibition on neuronal excitability varies across brain region and cell type.
Front. Neural Circuits 8, 3.
Lin, J.S., Sakai, K., and Jouvet, M. (1988). Evidence for histaminergic arousal
mechanisms in the hypothalamus of cat. Neuropharmacology 27, 111–122.
Lin, J.S., Sakai, K., Vanni-Mercier, G., and Jouvet, M. (1989). A critical role of
the posterior hypothalamus in the mechanisms of wakefulness determined by
microinjection of muscimol in freely moving cats. Brain Res. 479, 225–240.
Madisen, L., Zwingman, T.A., Sunkin, S.M., Oh, S.W., Zariwala, H.A., Gu, H.,
Ng, L.L., Palmiter, R.D., Hawrylycz, M.J., Jones, A.R., et al. (2010). A robust
and high-throughput Cre reporting and characterization system for the whole
mouse brain. Nat. Neurosci. 13, 133–140.
Monnier, M., Fallert, M., and Battacharya, I.C. (1967). The waking action of his-
tamine. Experientia 23, 21–22.
Nagel, G., Brauner, M., Liewald, J.F., Adeishvili, N., Bamberg, E., and
Gottschalk, A. (2005). Light activation of channelrhodopsin-2 in excitable cells
of Caenorhabditis elegans triggers rapid behavioral responses. Curr. Biol. 15,
2279–2284.
Nicholson, A.N., Pascoe, P.A., Turner, C., Ganellin, C.R., Greengrass, P.M.,
Casy, A.F., and Mercer, A.D. (1991). Sedation and histamine H1-receptor
antagonism: studies in man with the enantiomers of chlorpheniramine and
dimethindene. Br. J. Pharmacol. 104, 270–276.
Panula, P., Yang, H.Y., and Costa, E. (1984). Histamine-containing neurons in
the rat hypothalamus. Proc. Natl. Acad. Sci. USA 81, 2572–2576.
Panula, P., Pirvola, U., Auvinen, S., and Airaksinen, M.S. (1989). Histamine-
immunoreactive nerve fibers in the rat brain. Neuroscience 28, 585–610.
Parmentier, R., Ohtsu, H., Djebbara-Hannas, Z., Valatx, J.L., Watanabe, T.,
and Lin, J.S. (2002). Anatomical, physiological, and pharmacological charac-
teristics of histidine decarboxylase knock-out mice: evidence for the role of
brain histamine in behavioral and sleep-wake control. J. Neurosci. 22, 7695–
7711.
Parmentier, R., Kolbaev, S., Klyuch, B.P., Vandael, D., Lin, J.S., Selbach, O.,
Haas, H.L., and Sergeeva, O.A. (2009). Excitation of histaminergic tuberoma-
millary neurons by thyrotropin-releasing hormone. J. Neurosci. 29, 4471–4483.
Petreanu,L.,Huber,D.,Sobczyk,A., andSvoboda,K. (2007).Channelrhodopsin-
2-assisted circuit mapping of long-range callosal projections. Nat. Neurosci. 10,
663–668.
Pulver, S.R., Pashkovski, S.L., Hornstein, N.J., Garrity, P.A., and Griffith, L.C.
(2009). Temporal dynamics of neuronal activation by Channelrhodopsin-2 and
TRPA1 determine behavioral output in Drosophila larvae. J. Neurophysiol. 101,
3075–3088.
Roberts, E., and Sherman, M.A. (1993). GABA–the quintessential neurotrans-
mitter: electroneutrality, fidelity, specificity, and a model for the ligand binding
site of GABAA receptors. Neurochem. Res. 18, 365–376.
Root, D.H., Mejias-Aponte, C.A., Zhang, S., Wang, H.L., Hoffman, A.F.,
Lupica, C.R., and Morales, M. (2014). Single rodent mesohabenular axons
release glutamate and GABA. Nat. Neurosci. 17, 1543–1551.
Sakai, K., Takahashi, K., Anaclet, C., and Lin, J.S. (2010). Sleep-waking
discharge of ventral tuberomammillary neurons in wild-type and histidine de-
carboxylase knock-out mice. Front. Behav. Neurosci. 4, 53.
Saper, C.B., Fuller, P.M., Pedersen, N.P., Lu, J., and Scammell, T.E. (2010).
Sleep state switching. Neuron 68, 1023–1042.
Scho¨ne, C., and Burdakov, D. (2012). Glutamate and GABA as rapid effectors
of hypothalamic ‘‘peptidergic’’ neurons. Front. Behav. Neurosci. 6, 81.
Scho¨ne, C., Apergis-Schoute, J., Sakurai, T., Adamantidis, A., and Burdakov,
D. (2014). Coreleased orexin and glutamate evoke nonredundant spike out-
puts and computations in histamine neurons. Cell Rep. 7, 697–704.
Senba, E., Daddona, P.E., Watanabe, T., Wu, J.Y., and Nagy, J.I. (1985).
Coexistence of adenosine deaminase, histidine decarboxylase, and glutamate
decarboxylase in hypothalamic neurons of the rat. J. Neurosci. 5, 3393–3402.
Shabel, S.J., Proulx, C.D., Piriz, J., and Malinow, R. (2014). Mood regulation.
GABA/glutamate co-release controls habenula output and is modified by
antidepressant treatment. Science 345, 1494–1498.
Srinivas, S., Watanabe, T., Lin, C.S., William, C.M., Tanabe, Y., Jessell, T.M.,
and Costantini, F. (2001). Cre reporter strains produced by targeted insertion
of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4.
Neuron 87, 164–178, July 1, 2015 ª2015 The Authors 177
Stegmeier, F., Hu, G., Rickles, R.J., Hannon, G.J., and Elledge, S.J. (2005). A
lentiviral microRNA-based system for single-copy polymerase II-regulated
RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 102,
13212–13217.
Sundvik, M., and Panula, P. (2012). Organization of the histaminergic system in
adult zebrafish (Danio rerio) brain: neuron number, location, and cotransmit-
ters. J. Comp. Neurol. 520, 3827–3845.
Takagi, H., Morishima, Y., Matsuyama, T., Hayashi, H., Watanabe, T., and
Wada, H. (1986). Histaminergic axons in the neostriatum and cerebral cortex
of the rat: a correlated light and electron microscopic immunocytochemical
study using histidine decarboxylase as a marker. Brain Res. 364, 114–123.
Takahashi, K., Lin, J.S., and Sakai, K. (2006). Neuronal activity of hista-
minergic tuberomammillary neurons during wake-sleep states in the mouse.
J. Neurosci. 26, 10292–10298.
Takeda, N., Inagaki, S., Shiosaka, S., Taguchi, Y., Oertel, W.H., Tohyama, M.,
Watanabe, T., and Wada, H. (1984). Immunohistochemical evidence for the
coexistence of histidine decarboxylase-like and glutamate decarboxylase-
like immunoreactivities in nerve cells of the magnocellular nucleus of the pos-
terior hypothalamus of rats. Proc. Natl. Acad. Sci. USA 81, 7647–7650.
Tong, Q., Ye, C.P., Jones, J.E., Elmquist, J.K., and Lowell, B.B. (2008).
Synaptic release of GABA by AgRP neurons is required for normal regulation
of energy balance. Nat. Neurosci. 11, 998–1000.
Torrealba, F., Riveros, M.E., Contreras, M., and Valdes, J.L. (2012). Histamine
and motivation. Front. Syst. Neurosci. 6, 51.
Tritsch, N.X., Ding, J.B., and Sabatini, B.L. (2012). Dopaminergic neurons
inhibit striatal output through non-canonical release of GABA. Nature 490,
262–266.
Tritsch, N.X., Oh, W.J., Gu, C., and Sabatini, B.L. (2014). Midbrain dopamine
neurons sustain inhibitory transmission using plasma membrane uptake of
GABA, not synthesis. eLife 3, e01936.
Trottier, S., Chotard, C., Traiffort, E., Unmehopa, U., Fisser, B., Swaab, D.F.,
and Schwartz, J.C. (2002). Co-localization of histamine with GABA but not
with galanin in the human tuberomamillary nucleus. Brain Res. 939, 52–64.
Tye, K.M., and Deisseroth, K. (2012). Optogenetic investigation of neural cir-
cuits underlying brain disease in animal models. Nat. Rev. Neurosci. 13,
251–266.
Vaaga, C.E., Borisovska, M., and Westbrook, G.L. (2014). Dual-transmitter
neurons: functional implications of co-release and co-transmission. Curr.
Opin. Neurobiol. 29, 25–32.
van den Pol, A.N. (2012). Neuropeptide transmission in brain circuits. Neuron
76, 98–115.
Vincent, S.R., Ho¨kfelt, T., Skirboll, L.R., and Wu, J.Y. (1983). Hypothalamic
gamma-aminobutyric acid neurons project to the neocortex. Science 220,
1309–1311.
Vong, L., Ye, C., Yang, Z., Choi, B., Chua, S., Jr., and Lowell, B.B. (2011).
Leptin action on GABAergic neurons prevents obesity and reduces inhibitory
tone to POMC neurons. Neuron 71, 142–154.
Wada, H., Inagaki, N., Yamatodani, A., and Watanabe, T. (1991). Is the hista-
minergic neuron system a regulatory center for whole-brain activity? Trends
Neurosci. 14, 415–418.
Watanabe, T., Taguchi, Y., Hayashi, H., Tanaka, J., Shiosaka, S., Tohyama,M.,
Kubota, H., Terano, Y., and Wada, H. (1983). Evidence for the presence of a
histaminergic neuron system in the rat brain: an immunohistochemical anal-
ysis. Neurosci. Lett. 39, 249–254.
Williams, R.H., Chee, M.J., Kroeger, D., Ferrari, L.L., Maratos-Flier, E.,
Scammell, T.E., and Arrigoni, E. (2014). Optogenetic-mediated release of his-
tamine reveals distal and autoregulatory mechanisms for controlling arousal.
J. Neurosci. 34, 6023–6029.
Wisden, W., Cope, D., Klausberger, T., Hauer, B., Sinkkonen, S.T., Tretter, V.,
Lujan, R., Jones, A., Korpi, E.R., Mody, I., et al. (2002). Ectopic expression of
the GABA(A) receptor alpha6 subunit in hippocampal pyramidal neurons
produces extrasynaptic receptors and an increased tonic inhibition.
Neuropharmacology 43, 530–549.
Wlodarczyk, A.I., Xu, C., Song, I., Doronin, M., Wu, Y.W., Walker, M.C., and
Semyanov, A. (2013). Tonic GABAA conductance decreases membrane time
constant and increases EPSP-spike precision in hippocampal pyramidal neu-
rons. Front. Neural Circuits 7, 205.
Wojcik, S.M., Katsurabayashi, S., Guillemin, I., Friauf, E., Rosenmund, C.,
Brose, N., and Rhee, J.S. (2006). A shared vesicular carrier allows synaptic
corelease of GABA and glycine. Neuron 50, 575–587.
Yu, X., Zecharia, A., Zhang, Z., Yang, Q., Yustos, R., Jager, P., Vyssotski, A.L.,
Maywood, E.S., Chesham, J.E., Ma, Y., et al. (2014). Circadian factor BMAL1 in
histaminergic neurons regulates sleep architecture. Curr. Biol. 24, 2838–2844.
Zecharia, A.Y., Yu, X., Go¨tz, T., Ye, Z., Carr, D.R., Wulff, P., Bettler, B.,
Vyssotski, A.L., Brickley, S.G., Franks, N.P., and Wisden, W. (2012).
GABAergic inhibition of histaminergic neurons regulates active waking but
not the sleep-wake switch or propofol-induced loss of consciousness.
J. Neurosci. 32, 13062–13075.
178 Neuron 87, 164–178, July 1, 2015 ª2015 The Authors
